1. Home
  2. RLAY vs MHH Comparison

RLAY vs MHH Comparison

Compare RLAY & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • MHH
  • Stock Information
  • Founded
  • RLAY 2015
  • MHH 1986
  • Country
  • RLAY United States
  • MHH United States
  • Employees
  • RLAY N/A
  • MHH N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • MHH Professional Services
  • Sector
  • RLAY Health Care
  • MHH Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • MHH Nasdaq
  • Market Cap
  • RLAY 803.4M
  • MHH 86.6M
  • IPO Year
  • RLAY 2020
  • MHH N/A
  • Fundamental
  • Price
  • RLAY $6.49
  • MHH $6.71
  • Analyst Decision
  • RLAY Strong Buy
  • MHH
  • Analyst Count
  • RLAY 8
  • MHH 0
  • Target Price
  • RLAY $17.25
  • MHH N/A
  • AVG Volume (30 Days)
  • RLAY 1.7M
  • MHH 9.3K
  • Earning Date
  • RLAY 11-05-2025
  • MHH 11-05-2025
  • Dividend Yield
  • RLAY N/A
  • MHH N/A
  • EPS Growth
  • RLAY N/A
  • MHH N/A
  • EPS
  • RLAY N/A
  • MHH 0.07
  • Revenue
  • RLAY $8,355,000.00
  • MHH $200,000,000.00
  • Revenue This Year
  • RLAY $27.33
  • MHH N/A
  • Revenue Next Year
  • RLAY $7.40
  • MHH $3.78
  • P/E Ratio
  • RLAY N/A
  • MHH $91.14
  • Revenue Growth
  • RLAY N/A
  • MHH 5.16
  • 52 Week Low
  • RLAY $1.78
  • MHH $6.20
  • 52 Week High
  • RLAY $7.00
  • MHH $16.00
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 66.70
  • MHH 35.21
  • Support Level
  • RLAY $5.85
  • MHH $7.00
  • Resistance Level
  • RLAY $6.79
  • MHH $7.55
  • Average True Range (ATR)
  • RLAY 0.39
  • MHH 0.29
  • MACD
  • RLAY 0.03
  • MHH -0.05
  • Stochastic Oscillator
  • RLAY 66.58
  • MHH 21.07

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: